444

GENEREACH BIOTECHNOLOGY CORP

No trades
See on Supercharts

4171 fundamentals

GENEREACH BIOTECHNOLOGY CORP financial statements, including revenue, expenses, profit, and loss

The total revenue of 4171 for the last quarter is 62.46 M TWD, and it's 44.72% higher compared to the previous quarter. The net income of Q3 24 is -28.14 M TWD.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TWD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth